New Study Reveals COVID Vaccine Effectiveness Against Emerging Strains

A recent study from the University of Waterloo has provided valuable insights into the effectiveness of COVID-19 vaccines against emerging strains of the virus. Conducted by a team led by Yangjianchen Xu, an assistant professor in the Department of Statistics and Actuarial Science, the research analyzed data from approximately 1.8 million residents of Nebraska over a seven-month period from 2024 to 2025. The study aimed to assess whether existing vaccines remain effective amid the evolving landscape of COVID-19 variants.

The research team collaborated with experts from the UNC Gillings School of Global Public Health and the University of Nebraska Medical Center. The data utilized in the study was sourced from multiple platforms, including the Nebraska electronic disease surveillance system and hospital discharge data. Xu emphasized the need for such studies, stating, “These vaccines were authorized by the FDA in the U.S., but this authorization is not based on some clinical data. Our study aims to fill this gap by examining real-world data.”

The findings indicate that the latest vaccines demonstrate significant effectiveness against severe outcomes of COVID-19, such as hospitalization and death. The study found that vaccines were most protective four weeks post-vaccination, yielding an effectiveness of 44.7 percent against infection, 45.1 percent against emergency department visits, and 57.5 percent against hospitalization or death. However, the effectiveness waned over time, dropping to 35 percent against infection at ten weeks and further declining to 16.7 percent by twenty weeks.

Danyu Lin, the lead author and distinguished professor of biostatistics at the Gillings School, noted that this study is among the largest of its kind regarding vaccine effectiveness. He remarked, “Our study showed that vaccines in 2024 to 2025 were effective, especially against severe outcomes, although their effectiveness waned over time.” Lin also observed that vaccine effectiveness appeared consistent across different Omicron subvariants, suggesting that upcoming vaccines targeting similar strains might also be effective.

Implications for Public Health

As winter approaches, the urgency for vaccination increases, according to health professionals. Dr. Nicola Mercer, the medical officer of health for Wellington-Dufferin-Guelph Public Health, highlighted the broader implications of vaccination. “It impacts people who aren’t even sick. If you have to go to an emergency room or are waiting for surgery, high rates of illness can burden our healthcare system,” she explained. Mercer urged those hesitant about vaccines to consult their healthcare providers, emphasizing the importance of vaccinations for vulnerable populations, including newborns and the elderly.

In alignment with the study’s findings, David Aoki, director of infectious disease and chief nursing officer with Region of Waterloo Public Health, reinforced the message of vaccination. “We continue to offer COVID vaccines free of charge, and study after study has shown their effectiveness and safety,” he stated. Aoki pointed out that colder weather increases the likelihood of respiratory illnesses, making vaccination even more critical as people gather indoors.

The study underscores the importance of ongoing research to monitor vaccine effectiveness as the virus continues to evolve. Xu expressed hope for future studies that will evaluate the effectiveness of newly developed vaccines. “The current vaccine reaches peak effectiveness after about four weeks, but after that, its power begins to wane quickly,” he said.

As the global community navigates the ongoing challenges of COVID-19, this research provides essential information for public health strategies and individual decisions regarding vaccination.